Skip to main content
. Author manuscript; available in PMC: 2013 Apr 1.
Published in final edited form as: Eur J Neurol. 2011 Dec 5;19(4):625–630. doi: 10.1111/j.1468-1331.2011.03598.x

Table 1.

Clinical Characteristics of 20 ET Cases and 19 Controls

ET Cases Controls Significance

Age (years) 81.8 ± 7.7 79.4 ± 9.8 p = 0.40 a

Female gender 13 (65.0%) 9 (47.4%) p = 0.27 b

Tremor duration (years) 43.1 ± 23.2 Not applicable Not applicable

Postmortem interval (hours) 3.4 ± 3.1 7.7 ± 7.5 p = 0.03 a

Brain weight (grams) 1245.7 ± 136.5 1243.7 ± 122.2 p = 0.40 a

CERAD plaque score p = 0.43 b
 0 10 (50.0%) 13 (68.4%)
 A 7 (35.0%) 5 (26.3%)
 B 3 (15.0%) 1 (5.3%)
 C 0 (0.0%) 0 (0.0%)

Braak AD stage p = 0.02 b
 0 1 (5.0%) 6 (31.6%)
 1 7 (35.0%) 7 (36.8%)
 2 6 (30.0%) 6 (31.6%)
 3 6 (30.0%) 0 (0.0%)
 4 0 (0.0%) 0 (0.0%)
 5 0 (0.0%) 0 (0.0%)
 6 0 (0.0%) 0 (0.0%)

Torpedo count (LH&E) 14.5 ± 14.2 3.0 ± 3.7 p = 0.002 a

Torpedo count (Bielschowsky) 29.3 ± 31.3 6.4 ± 10.4 p = 0.005 a

Purkinje cell count (LH&E) 36.1 ± 8.8 45.5 ± 13.9 p = 0.03 a

Basket cell axonal plexus density 2.2 ± 0.7 1.4 ± 0.6 p = 0.003 c

All values are mean ± standard deviation or number (percentage).

a

Student’s t test,

b

Chi-square or Fisher’s Exact test,

c

Mann-Whitney test